Search
Search Results
##search.searchResults.foundPlural##
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1727PDF: 1120HTML: 156 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1988PDF: 2194Suppl. Files: 303HTML: 129 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13082PDF: 1798HTML: 4385Cover letter: 311Figure 1: 333 -
The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia
963PDF: 478HTML: 397 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2214PDF: 193HTML: 53 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2379PDF: 953HTML: 391 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1359PDF: 871HTML: 270 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3537PDF: 1720HTML: 306 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2970PDF: 1067HTML: 4763 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
5027PDF: 1656HTML: 2291Untitled: 289Untitled: 310Untitled: 330Untitled: 284Untitled: 294 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1325PDF: 767HTML: 524 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1349PDF: 599HTML: 1730Figures: 223Fifures Sanz: 234tables Sanz: 238Untitled: 229 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3693PDF: 1393HTML: 2428Fi.1 Gritti.Rambaldi: 280 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2407PDF: 1095HTML: 4999 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3635PDF: 1373HTML: 8441 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3499PDF: 1994HTML: 3746 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2524PDF: 824HTML: 2160Untitled: 311Untitled: 206Untitled: 246Untitled: 223Untitled: 249Untitled: 260Untitled: 254 -
Anemia in the elderly: not always what it seems.
3478PDF: 1194HTML: 1828Figure 1: 268Figure 1 revised: 315 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1435PDF: 1211PDF: 981HTML: 274 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6031PDF: 1641HTML: 1690Untitled: 297 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2482PDF: 1051HTML: 536Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 285UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 429Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 335Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 235Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 260Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 344 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1106PDF: 621HTML: 2240Cover Letter: 273 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3511PDF: 1659HTML: 570 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2705PDF: 1435HTML: 1881CoverLetter: 246 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1815PDF: 1098HTML: 1903Untitled: 265Untitled: 235 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
1421PDF: 581HTML: 168 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2837PDF: 1286HTML: 297







